Comparison of Clinical and Epidemiological Characteristics of Deceased and Recovered Patients with COVID-19 in Sabzevar, Iran

Document Type : Original Research

Authors

1 center clinical research of sabzevar vasei hospital

2 sabzevar university of medical sciences

3 Clinical Research Center of Sabzevar Vasei Hospital, Sabzevar University of Medical Sciences, Sabzevar, Iran

Abstract

Background and Aim: SARS-CoV-2 is the most dangerous virus in the coronavirus family and is a serious warning to all countries in the world. Despite the efforts of researchers, there are widespread ambiguities about it. The aim of this study was to compare the clinical and epidemiological characteristics of deceased and recovered patients with COVID-19.
Methods: This descriptive-analytical study was performed in patients with COVID-19 in Vasei Hospital in Sabzevar, Iran in March and April 2020. The tools used were the researcher-made questionnaire, interview and medical files.
Results: From the 178 patients, 52.8% were women and the mean age was 57.1±18 years. 85.4% have recovered and 14% have died. Shortness of breath (72.5%) was the most common symptom, followed by cough (61.8%) and fever (48.9%). 43.8% of all patients and 71.9% of deceased patients had at least one underlying disease. There were significant differences in terms of cough in recovered cases and decreased level of consciousness in deceased patients (P <0.05). Increased white blood cell counts, decreased lymphocytes, and increased neutrophils were significantly higher in deceased patients (P <0.05)
Conclusion: Due to the high rate of infection and death in older people with underlying diseases, precautionary measures should be taken in this group. It is also helpful to pay attention to patients' symptoms in admission to identify the patient's prognosis. An increase in white blood cells and neutrophils and a decrease in lymphocytes indicate that the immune system is involved in these patients. More research is needed to identify the pathogenesis and underlying factors in these patients.

Keywords

References

1. Rodriguez-Morales A.J, Cardona-Ospina JA, Gutierrez-Ocampo E, Villamizar-Pena R, Holguin-Rivera Y, Escalera-Antezana J, et al. Travel Medicine and Infectious Disease. 10.1016/j.tmaid.2020.101623. doi:10.1016/j.tmaid.2020.101623. 2. Su L, Ma X, Yu H, Zhang Z, Bian P,Han Y, et al. The different clinical characteristics of corona virus disease cases between children and their families in China – the character of children with COVID-19. Emerging Microbes & Infections.2020; 9:706-713.doi:10.1080/22221751.2020.1744483 3. Hasheminik M, Parsaeimehr Z, Jamalinik M, Tajabadi A. The Challenge of Transmission Chain and Effective Hospital Strategies in Controlling the Prevalence of Covid-19. J Mil Med. 2020; 22 (2) :205-206. 4. Cui J, Li F,Shi Z. Origin and evolution of pathogenic coronaviruses. MiCRobiology. 2019; 17:181-92. doi:10.1038/s41579-018-0118-9. 5. World Helath Organization. 2019- nCoV Situation Report-22 on 20 May, 2020. https://www.who.int/docs/defaultsource/ coronaviruse/situation-reports. 6. Farnoosh G, Ghanei M, Khorramdelazad H, Alishiri G, Farahani AJ, Shahriary A. Are Iranian Sulfur mustard-exposed survivors more vulnerable to SARS-CoV-2: some similarity in their pathogenesis. Articles in Press. doi: 10.1017/dmp.2020.156. 7. Nikpouraghdam M, Farahani AJ, Alishiri G, Heydari S, Ebrahimnia M, Samadinia H,et al. Epidemiological Characteristics of Coronavirus Disease 2019 (COVID-19) Patients in IRAN: A single Center Study, Journal of Clinical Virology (2020). Articles in Press doi: 10.1016/j.jcv.2020.104378. 8. Yang X ,Yu Y, Shu H, Liu H, Wu Y , Zhang L, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020: 1-7. doi: 10.1016/S2213-2600(20)30079-5. 9. Yang W, Cao Q, Qin L, Wang X, Cheng Z, Pan A, et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): A multi-center study in Wenzhou city, Zhejiang, China. Journal homepage. 2020; 80: 388-93. doi: 10.1016/j.jinf.2020.02.016. 10. Tavakoli A, vahdat K, keshavar M. NovelCoronavirusDisease 2019 (COVID-19): An Emergening Infectious Disease in the 21 st Century. Iran South MedJ. 2020;22(6):432-450. 11. Rio C, Malani P. COVID-19 New Insights on A Rapidly Changing Epidemic. JAMA.2020; 323 (14): 1339-1340. doi:10.1001/jama.2020.3072. 12. Zu ZY, Jiang MD, Xu PP, Chen W, Chen W, Ni Q , et al. Coronavirus Disease 2019 (COVID-19): A Perspective from China. Rdiology. Articles in Press. 13. Xia W, Shao J, Guo Y, Peng X, Li Z, Hu D. Clinical and CT features in pediatric patients with COVID‐19 infection: Different points from adults. Pediatric Pulmonology. 2020; 55:1169–1174. doi:10.1002/ppul.24718. 14. Huang C, Wang Y, Li X, Ran L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet .2020; 395: 497–506. doi:10.1016/S0140-6736. 15. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020; 395 (10223): 507-13. doi:10.1016/ S0140-6736(20)30211-7 16. Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet. 2020. doi 10.1016/S0140-6736(20)30154-9. 17. Bernheim A, Mei X, Huang M, Yang Y, Fayad Z, Zhang N, et al. Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection. Radiology. 2020; 295:685–691. doi:10.1148/radiol.2020200463 18. Farnoosh G, Alishiri G, Hosseini Zijoud SR, Dorostkar R, Jalali Farahani A. Understanding the 2019-novel Coronavirus (2019-nCoV) and Coronavirus Disease (COVID-19) Based on Available Evidence - A Narrative Review. Journal of Military Medicine. 2020;22(1): 1-11. doi:10.30491/JMM.22.1.1 19. Guan W, Ni Z, liang W, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicin.2020;382: 1708-1720. doi: 10.1056/ NEJMoa2002032. 20. Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature 2020; 579(7798):265–9. doi:10.1038/s41586-020-2008-3. 21. Chen T, Wu Di, Chen H, Yan W, Yang D, Chen G, et al . Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368: 1-14. doi:10.1136/bmj.m1091 22. Chen J, Qi T, Liu L, Ling Y, Qian Z, Li T, et al, Clinical progression of patients with COVID-19 in Shanghai, China. Journal of Infection. 2020:80; e1–e6. doi:10.1016/j.jinf.2020.03.004 23. Li X, Wang L, Yan Sh, Yang F, Xiang L,Zhu J, et al. Clinical characteristics of 25 death cases with COVID-19: A retrospective review of medical records in a single medical center, Wuhan, China. International Journal of Infectious Diseases.2020: 94; 128–132. doi:10.1016/j.ijid.2020.03.053. 24. Du Y, Tu Lei, Zhu P, Mu M, Wang R, Yang P, et al. Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan: A Retrospective Observational Study. AJRCCM. Articles in Press. doi:0.1164/rccm.202003-0543OC. 25. Zheng F, Tang W, Li H, Huang YX, Zia YL, Zhou ZG. Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha. European Review for Medical and Pharmacological Sciences. 2020; 24: 3404-3410. doi:10.1136/bmj.m1091 26. Yang F, Shi Sh, Zhu J, Shi J, Dai K, Chen X. Analysis of 92 deceased patients with COVID-19 .Articles in Press. doi:10.1002/jmv.25891. 27. Wang D, Hu B, Hu Ch, Zhu F, Liu X, Zhang J. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. doi:10.1001/jama.2020.1585 28. Wu Z, Jennifer M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. Published online February 24, 2020. doi:10.1001/jama.2020.2648. 29. Sahin A, Erdogan A, Agaoglu P, Dineri Y,Cakirci AY,Senel ME, et al. 2019 Novel Coronavirus (COVID-19) Outbreak: A Review of the Current Literature. EJMO. 2020;4(1):1–7. doi:10.14744/ejmo.2020.12220. 30. Mark M. Epidemiology and clinical characteristics of 50 death cases with Covid-2019 in the Philippines: A retrospective review. (April 3, 2020) Articles in Press. SSRN. doi:10.2139/ssrn.3570612. 31. Wu J, Liu J, Zhao X, Liu Ch, Wang W, Wang D, et al. Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study. Infectious Diseases Society of America. Articles in Press. doi/10.1093/cid/ciaa199/5766408. 32. Rothan H. Byrareddy S. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity. 2020;109(102433): 1-4. doi:10.1016/j.jaut.2020.102433. 33. Mardani R, Ahmadi Vasmehjani A, Zali F, Gholami A,Mousavi Nasab S D, Kaghazian H, Kaviani M, Ahmadi N. Laboratory Parameters in Detection of COVID-19 Patients with Positive RT-PCR; a Diagnostic Accuracy Study. Arch Acad EmergMed. 2020; 8(1): e43.
Journal of Military Medicine
Volume 22, Issue 6 - Serial Number 91
July and August 2020
Pages 509-516

Files

Share

How to cite

Statistics